Padraig R Warde, MB BCh, FRCPC

Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
https://orcid.org/0000-0002-4236-0026
Keywords: clinical trials, prostate cancer, testicular cancer
Local Failure in High-grade Prostate Cancer: An Elusive but Important Outcome and Target for Clinical Trials.
Eur Urol. 2019 Nov 28;:
Alibhai SMH, Warde P
Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles.
Front Cell Infect Microbiol. 2019;9:324
Kosgodage US, Matewele P, Awamaria B, Kraev I, Warde P, Mastroianni G, Nunn AV, Guy GW, Bell JD, Inal JM, Lange S
Defining advanced practice in radiation therapy: A feasibility assessment of a new healthcare provider role in Ontario, Canada.
Radiography (Lond). 2019 Aug;25(3):241-249
Harnett N, Bak K, Zychla L, Gutierrez E, Warde P
Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours.
Eur Urol Oncol. 2019 Jul;2(4):437-442
Chung P, O'Malley ME, Jewett MAS, Bedard PL, Panzarella T, Sturgeon J, Moore MJ, Hamilton R, Hansen AR, Anson-Cartwright L, Gospodarowicz M, Warde P
Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred Option.
Eur Urol Focus. 2019 May 22;:
Hamilton RJ, Jewett MAS, Warde P, Hansen A
Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.
J Clin Oncol. 2019 Feb 25;:JCO1801250
Hamilton RJ, Nayan M, Anson-Cartwright L, Atenafu EG, Bedard PL, Hansen A, Chung P, Warde P, Sweet J, O'Malley M, Sturgeon J, Jewett MAS
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors.
JCO Clin Cancer Inform. 2018 Dec;(2):1-12
Lewin J, Dufort P, Halankar J, O'Malley M, Jewett MAS, Hamilton RJ, Gupta A, Lorenzo A, Traubici J, Nayan M, Leão R, Warde P, Chung P, Anson Cartwright L, Sweet J, Hansen AR, Metser U, Bedard PL
A phase I pilot study of pre-operative radiotherapy for prostate cancer: Long-term toxicity and oncologic outcomes.
Int J Radiat Oncol Biol Phys. 2019 Jan 06;:
Glicksman R, Sanmamed N, Thoms J, Zlotta AR, Finelli A, van der Kwast T, Sweet J, Jewett M, Klotz LH, Rosewall T, Fleshner NE, Bristow RG, Warde P, Berlin A
A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
BMC Cancer. 2019 Jan 03;19(1):2
Alibhai SMH, Santa Mina D, Ritvo P, Tomlinson G, Sabiston C, Krahn M, Durbano S, Matthew A, Warde P, O'Neill M, Timilshina N, Segal R, Culos-Reed N
Improving Quality of Radiotherapy Care across Ontario Using a Community of Practice Approach.
Pract Radiat Oncol. 2018 Nov 14;:
Glicksman R, Ang M, Murray E, Simniceanu C, Lockhart E, Gilbert J, Gutierrez E, Warde P

Pages


 
Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Professor, Department of Radiation Oncology, University of Toronto​